Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
US6689363B1 · kind B1 · utility
37Cited by
16References
55Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 1999 |
| Grant date | Feb 10, 2004 |
| Priority date | — |
| Expiry date | Jan 27, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to develop epitope-based vaccines directed towards HBV. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of HBV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.